ACAD Historical PE Ratio image   This ACAD PE ratio history page last updated 5/17/2024
ACAD Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
5/8/2024
17.130.100.4042.8
Q4 2023
2/27/2024
26.360.281.1223.5
Q3 2023
11/2/2023
22.99-0.40-1.60NA
Q2 2023
8/2/2023
29.200.010.04>500
Q1 2023
5/8/2023
21.55-0.27-1.08NA
Q4 2022
2/27/2023
19.40-0.26-1.04NA
Q3 2022
11/2/2022
15.93-0.17-0.68NA
Q2 2022
8/8/2022
16.62-0.21-0.84NA
Q1 2022
5/4/2022
19.89-0.70-2.80NA
Q4 2021
2/28/2022
25.41-0.27-1.08NA
Q3 2021
11/8/2021
19.57-0.09-0.36NA
Q2 2021
8/4/2021
21.05-0.27-1.08NA
Q1 2021
5/5/2021
19.40-0.42-1.68NA
Q4 2020
2/24/2021
48.69-0.42-1.68NA
Q3 2020
11/4/2020
49.13-0.54-2.16NA
Q2 2020
8/5/2020
42.87-0.27-1.08NA
Q1 2020
5/7/2020
49.34-0.57-2.28NA
Q4 2019
2/26/2020
40.22-0.34-1.36NA
Q3 2019
10/30/2019
43.05-0.29-1.16NA
Q2 2019
7/31/2019
24.58-0.38-1.52NA
Q1 2019
5/1/2019
23.66-0.59-2.36NA
Q4 2018
2/26/2019
23.56-0.50-2.00NA
Q3 2018
11/6/2018
21.88-0.50-2.00NA
Q2 2018
8/8/2018
14.02-0.51-2.04NA
Q1 2018
5/4/2018
17.80-0.44-1.76NA
Q4 2017
2/27/2018
31.16-0.55-2.20NA
Q3 2017
11/7/2017
32.46-0.53-2.12NA
Q2 2017
8/8/2017
29.54-0.55-2.20NA
Q1 2017
5/9/2017
32.26-0.72-2.88NA
Q4 2016
2/28/2017
38.11-0.65-2.60NA
Q3 2016
11/7/2016
22.99-0.61-2.44NA
Q2 2016
8/4/2016
36.48-0.63-2.52NA
Q1 2016
5/5/2016
27.05-0.45-1.80NA
Q4 2015
2/29/2016
17.26-0.45-1.80NA
Q3 2015
11/5/2015
41.54-0.39-1.56NA
Q2 2015
8/6/2015
45.15-0.39-1.56NA
Q1 2015
5/7/2015
36.56-0.40-1.60NA
Q4 2014
2/26/2015
37.78-0.28-1.12NA
Q3 2014
11/10/2014
28.21-0.25-1.00NA
Q2 2014
8/5/2014
20.77-0.22-0.88NA
Q1 2014
5/6/2014
19.16-0.19-0.76NA
Q4 2013
2/27/2014
30.10-0.13-0.52NA
Q3 2013
11/6/2013
21.00-0.12-0.48NA
Q2 2013
8/6/2013
20.68-0.11-0.44NA
Q1 2013
5/7/2013
12.03-0.08-0.32NA
Q4 2012
3/12/2013
6.31-0.11-0.44NA
Q3 2012
11/5/2012
2.27-0.04-0.16NA
Q2 2012
8/8/2012
1.50-0.10-0.40NA
Q1 2012
5/1/2012
1.56-0.12-0.48NA
ACAD PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
5/8/2024
17.130.10-0.01NA
Q4 2023
2/27/2024
26.360.28-0.38NA
Q3 2023
11/2/2023
22.99-0.40-0.92NA
Q2 2023
8/2/2023
29.200.01-0.69NA
Q1 2023
5/8/2023
21.55-0.27-0.91NA
Q4 2022
2/27/2023
19.40-0.26-1.34NA
Q3 2022
11/2/2022
15.93-0.17-1.35NA
Q2 2022
8/8/2022
16.62-0.21-1.27NA
Q1 2022
5/4/2022
19.89-0.70-1.33NA
Q4 2021
2/28/2022
25.41-0.27-1.05NA
Q3 2021
11/8/2021
19.57-0.09-1.20NA
Q2 2021
8/4/2021
21.05-0.27-1.65NA
Q1 2021
5/5/2021
19.40-0.42-1.65NA
Q4 2020
2/24/2021
48.69-0.42-1.80NA
Q3 2020
11/4/2020
49.13-0.54-1.72NA
Q2 2020
8/5/2020
42.87-0.27-1.47NA
Q1 2020
5/7/2020
49.34-0.57-1.58NA
Q4 2019
2/26/2020
40.22-0.34-1.60NA
Q3 2019
10/30/2019
43.05-0.29-1.76NA
Q2 2019
7/31/2019
24.58-0.38-1.97NA
Q1 2019
5/1/2019
23.66-0.59-2.10NA
Q4 2018
2/26/2019
23.56-0.50-1.95NA
Q3 2018
11/6/2018
21.88-0.50-2.00NA
Q2 2018
8/8/2018
14.02-0.51-2.03NA
Q1 2018
5/4/2018
17.80-0.44-2.07NA
Q4 2017
2/27/2018
31.16-0.55-2.35NA
Q3 2017
11/7/2017
32.46-0.53-2.45NA
Q2 2017
8/8/2017
29.54-0.55-2.53NA
Q1 2017
5/9/2017
32.26-0.72-2.61NA
Q4 2016
2/28/2017
38.11-0.65-2.34NA
Q3 2016
11/7/2016
22.99-0.61-2.14NA
Q2 2016
8/4/2016
36.48-0.63-1.92NA
Q1 2016
5/5/2016
27.05-0.45-1.68NA
Q4 2015
2/29/2016
17.26-0.45-1.63NA
Q3 2015
11/5/2015
41.54-0.39-1.46NA
Q2 2015
8/6/2015
45.15-0.39-1.32NA
Q1 2015
5/7/2015
36.56-0.40-1.15NA
Q4 2014
2/26/2015
37.78-0.28-0.94NA
Q3 2014
11/10/2014
28.21-0.25-0.79NA
Q2 2014
8/5/2014
20.77-0.22-0.66NA
Q1 2014
5/6/2014
19.16-0.19-0.55NA
Q4 2013
2/27/2014
30.10-0.13-0.44NA
Q3 2013
11/6/2013
21.00-0.12-0.42NA
Q2 2013
8/6/2013
20.68-0.11-0.34NA
Q1 2013
5/7/2013
12.03-0.08-0.33NA
Q4 2012
3/12/2013
6.31-0.11-0.37NA
Q3 2012
11/5/2012
2.27-0.04NANA
Q2 2012
8/8/2012
1.50-0.10NANA
Q1 2012
5/1/2012
1.56-0.12NANA
Quotes delayed 20 minutes

Email EnvelopeFree ACAD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ACADIA Pharmaceuticals (ACAD) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ACCD PE Ratio History
ACER PE Ratio History
ACET PE Ratio History
ACGN PE Ratio History
ACHC PE Ratio History
ACHV PE Ratio History
ACLX PE Ratio History
ACOR PE Ratio History
ACRS PE Ratio History
ACRV PE Ratio History
How should the ACAD historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like ACADIA Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ACAD Historical PE Ratio page.

What is the average historical PE for ACAD based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ACAD historical PE ratio using the annualized quarterly earnings method works out to 33.1.

What is the average historical PE for ACAD based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ACAD historical PE ratio using the TTM earnings method works out to NA.

What is the average historical PE for ACAD based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The ACAD historical PE ratio using the annualized median TTM earnings method works out to 0.24.

On this page we presented the ACAD Historical PE Ratio information for ACADIA Pharmaceuticals' stock. The average ACAD historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 33.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ACAD historical PE based on this TTM earnings result method is NA. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ACAD historical PE result, against the recent PE: when this page was posted on 5/16/2024, the most recent closing price for ACAD had been 14.85, and the most recent quarterly earnings result, annualized, was 0.4. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent ACAD PE on 5/16/2024 based on annualized quarterly EPS was 37.1. Based on ACAD's history, that recent PE is elevated relative to the historical average, with the recent PE 12.1% higher than the historical average PE across our data set for ACADIA Pharmaceuticals.

Another interesting ACAD historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for ACAD, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for ACAD, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.40, 0.01, 0.10, and 0.28. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.01 and 0.10 — which gives us the median of 0.06. Basically the way to think about this 0.06 number is this: for the trailing four earnings reports, 0.06 marks the "middle ground" number where ACAD has reported a value higher than 0.06 half the time, and has reported a value lower than 0.06 half the time. Annualizing that median value then gets us to 0.24/share, which we use as the denominator in our next PE calculation. With 14.85 as the numerator (as of 5/16/2024), the calculation is then 14.85 / 0.24 = 61.9 as the ACAD PE ratio as of 5/16/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on ACAD or any other given stock, valuation analysis for ACAD can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate ACADIA Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ACAD. Thanks for visiting, and the next time you need to research ACAD Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding LGHT, TEF YTD Return, XNTK market cap history.

 

ACAD Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.